白云山(00874.HK) 公布,持股90.92%的非全资附属公司广州医药,于11月28日与兴证资管签订新增基础资产交割确认函,向兴证资管出售第一次新增基础资产,即是账面值为约5.31亿元人民币的应收账款,代价为5.24亿元人民币。
公司表示,广州医药通过交易可利用应收账款进行资产证券化,从而将应收账款转变为流动性较高的现金资产,达到盘活资产存量的目的。(gc/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-28 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.